Trade Mark Journal No.2024/040 4 October 2024

WO0000001810489 (5)

Office of origin: United States of America

Date of International Registration:2 July 2024
Date of designation in the UK: 2 July 2024
Image for mark 1810489

The mark consists of four overlapping circle designs.

International priority date claimed: 6 June 2024 (United States of America) (98588346)
Class 5
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.

Bridgebio Pharma, Inc.

Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA